Last summer, the FDA alerted the pharmaceutical industry that any clinical tests conducted between April 2005 and June 2010 by a contract research organization called Cetero Research may have to be reevaluated because two agency inspections and an outside audit found falsified data and manipulated samples (back story). So which companies need to have studies reworked?
